chr16-56865482-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The ENST00000563236.6(SLC12A3):c.247C>T(p.Arg83Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,613,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R83Q) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000563236.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.247C>T | p.Arg83Trp | missense_variant | 1/26 | ENST00000563236.6 | NP_001119580.2 | |
SLC12A3 | NM_000339.3 | c.247C>T | p.Arg83Trp | missense_variant | 1/26 | NP_000330.3 | ||
SLC12A3 | NM_001126107.2 | c.247C>T | p.Arg83Trp | missense_variant | 1/26 | NP_001119579.2 | ||
SLC12A3 | NM_001410896.1 | c.247C>T | p.Arg83Trp | missense_variant | 1/26 | NP_001397825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.247C>T | p.Arg83Trp | missense_variant | 1/26 | 1 | NM_001126108.2 | ENSP00000456149 | A1 | |
SLC12A3 | ENST00000438926.6 | c.247C>T | p.Arg83Trp | missense_variant | 1/26 | 1 | ENSP00000402152 | A1 | ||
SLC12A3 | ENST00000566786.5 | c.247C>T | p.Arg83Trp | missense_variant | 1/26 | 1 | ENSP00000457552 | P4 | ||
SLC12A3 | ENST00000262502.5 | c.247C>T | p.Arg83Trp | missense_variant | 1/26 | 5 | ENSP00000262502 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250818Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135678
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461424Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727048
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74498
ClinVar
Submissions by phenotype
Familial hypokalemia-hypomagnesemia Pathogenic:7
Likely pathogenic, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Sep 06, 2019 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The SLC12A3 c.247C>T (p.Arg83Trp) variant is reported in one study in which it is found in a compound heterozygous state with another missense variant in five patients with Gitelman syndrome (Vargas-Poussou et al. 2011). The p.Arg83Trp variant was absent from 200 control chromosomes and is reported at a frequency of 0.00005 in the European (non-Finnish) population of the Exome Aggregation Consortium database. Based on the evidence, the p.Arg83Trp variant is classified as likely pathogenic for Gitelman syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | May 05, 2023 | Criteria applied: PS3,PM3,PM5,PM2_SUP,PP4 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | European Hospital Georges Pompidou Genetics Department, Assistance Publique - Hôpitaux de Paris AP-HP | Apr 27, 2022 | ACMG criteria used:PS3, PM1, PM2, PP3, PP5, PM3 - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 29, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 19, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 83 of the SLC12A3 protein (p.Arg83Trp). This variant is present in population databases (rs201255508, gnomAD 0.006%). This missense change has been observed in individuals with SLC12A3-related conditions (PMID: 21415153). ClinVar contains an entry for this variant (Variation ID: 319889). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A3 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SLC12A3 function (PMID: 27582097). This variant disrupts the p.Arg83 amino acid residue in SLC12A3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20675610, 21051746, 21415153). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at